Dexamethasone isn’t the only steroid that has shown promise in the battle against COVID-19.
Researchers at the Albert Einstein College of Medicine and Montefiore Health System led a study in which most of their patients took prednisone, another steroid in the same family as dexamethasone, and found patients with high inflammation levels were associated with a 75% reduction in risk of going on mechanical ventilation or dying.
The study, published in the peer-reviewed Journal of Hospital Medicine, also sought to pinpoint a window in which these steroids would be the most beneficial to patients with COVID-19, the illness caused by SARS-CoV-2 virus.
Authors of the Einstein-Montefiore study found a simple blood test could dictate when a doctor should treat their patient with steroids. The blood test measures levels of C-reactive protein, which the liver produces in response to inflammation.
Read more at USA Today.